Pfizer Halts Oral GLP-1 Drug Danuglipron Development Amid Liver Safety Concerns Read More GO Prime with only $1.49 now LATEST Cytiva Partners with Mycenax Biotech to Build AI-Driven and Future-Ready Downstream Bioprocessing 2026-08-03 Huaulu Community Replaces Seram Cockatoo Feathers in Initiation Rites to Aid Conservation 2026-08-03 EVENT 2026-08-07 Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech) Taipei, Taiwan 2026-09-02 BIO Asia Pacific (APAC Biotech & Smart Health) Bangkok, Thailand 2026-09-16 BIOHK (1619, Hong Kong) (Hong Kong biotech & investment) Hong Kong 2026-10-07 BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative) Yokohama, Japan 2026-10-07 Hospital Expo Tokyo (Devices & Hospital IT) Tokyo, Japan 2026-10-20 AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment) Queensland, Australia
A steady schedule helps prevent missing or delaying doses
Lack of FDA Approval : Compounded drugs do not undergo the rigorous FDA review process, raising questions about their quality and consistency
One commenter wrote, "Our soda and ice machines have tasted like mildew for ages
It should be noted that direct comparisons between retatrutide and other agents such as semaglutide or tirzepatide are not straightforward, as trials differ in design, population, duration, and endpoints